Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study
Stefan P. Berger, Claudia Sommerer, Oliver Witzke, Helio Tedesco, Steve Chadban, Shamkant Mulgaonkar, Yasir Qazi, Johan W. De Fijter, Federico Oppenheimer, Josep M. Cruzado, Yoshihiko Watarai, Pablo Massari, Pietro Massari, Christophe Legendre, Franco Citterio, Mitchell Henry, Titte R. Srinivas, Flavio Vincenti, Maria Pilar Hernandez Gutierrez, Ana Maria MartiPeter Bernhardt, Julio Pascual
Entra nei temi di ricerca di 'Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study'. Insieme formano una fingerprint unica.